Cyclosporin A response and dependence in children with acquired aplastic anaemia

A multicentre retrospective study with long-term observation follow-up

Paola Saracco, Paola Quarello, Anna Paola Iori, Marco Zecca, Daniela Longoni, Johanna Svahn, Stefania Varotto, Gian Carlo Del Vecchio, Carlo Dufour, Ugo Ramenghi, Andrea Bacigalupo, Anna Locasciulli

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

Immunosuppressive therapy (IST) with antithymocyte globulin and cyclosporin A (CyA) is the standard treatment for children with acquired aplastic anaemia (AAA) lacking a matched donor. Survival rates of more than 80% at 5 years are achieved, but the response is drug-dependent in 15-25% of cases. This study, of 42 consecutive children with AAA treated with IST, assessed the incidence of CyA-dependence, CyA and granulocyte colony-stimulating factor (G-CSF) tapering schedules and the impact of drug accumulation on progression to myelodysplasia/acute myeloid leukaemia (MDS/AML). Overall survival was 83% at 10 years. CyA-dependence without a predictive marker was observed in 18% of responders. Probability of discontinuing CyA was 60.5% at 10 years; a slow CyA tapering schedule was performed in 84% of patients; the cumulative incidence of relapse was 16% at 10 years. Relapse risk was significantly associated with rapid CyA discontinuation: 60% compared to 7.6% in the slow tapering group (P = 0.001). Cumulative incidence of MDS/AML was 8% at 10 years, with a significant correlation with both G-CSF cumulative dose and second IST. This long-term follow-up of children with AAA shows that IST with a slow CyA tapering course is an effective treatment with a low-relapse rate in these cases.

Original languageEnglish
Pages (from-to)197-205
Number of pages9
JournalBritish Journal of Haematology
Volume140
Issue number2
DOIs
Publication statusPublished - Jan 2008

Fingerprint

Aplastic Anemia
Cyclosporine
Multicenter Studies
Retrospective Studies
Observation
Immunosuppressive Agents
Granulocyte Colony-Stimulating Factor
Acute Myeloid Leukemia
Recurrence
Incidence
Appointments and Schedules
Therapeutics
Antilymphocyte Serum
Pharmaceutical Preparations
Survival Rate
Tissue Donors
Survival

Keywords

  • Aplastic anaemia
  • Children
  • Therapy

ASJC Scopus subject areas

  • Hematology

Cite this

Cyclosporin A response and dependence in children with acquired aplastic anaemia : A multicentre retrospective study with long-term observation follow-up. / Saracco, Paola; Quarello, Paola; Iori, Anna Paola; Zecca, Marco; Longoni, Daniela; Svahn, Johanna; Varotto, Stefania; Del Vecchio, Gian Carlo; Dufour, Carlo; Ramenghi, Ugo; Bacigalupo, Andrea; Locasciulli, Anna.

In: British Journal of Haematology, Vol. 140, No. 2, 01.2008, p. 197-205.

Research output: Contribution to journalArticle

Saracco, Paola ; Quarello, Paola ; Iori, Anna Paola ; Zecca, Marco ; Longoni, Daniela ; Svahn, Johanna ; Varotto, Stefania ; Del Vecchio, Gian Carlo ; Dufour, Carlo ; Ramenghi, Ugo ; Bacigalupo, Andrea ; Locasciulli, Anna. / Cyclosporin A response and dependence in children with acquired aplastic anaemia : A multicentre retrospective study with long-term observation follow-up. In: British Journal of Haematology. 2008 ; Vol. 140, No. 2. pp. 197-205.
@article{4266225296614da4a32f8b3666925e3c,
title = "Cyclosporin A response and dependence in children with acquired aplastic anaemia: A multicentre retrospective study with long-term observation follow-up",
abstract = "Immunosuppressive therapy (IST) with antithymocyte globulin and cyclosporin A (CyA) is the standard treatment for children with acquired aplastic anaemia (AAA) lacking a matched donor. Survival rates of more than 80{\%} at 5 years are achieved, but the response is drug-dependent in 15-25{\%} of cases. This study, of 42 consecutive children with AAA treated with IST, assessed the incidence of CyA-dependence, CyA and granulocyte colony-stimulating factor (G-CSF) tapering schedules and the impact of drug accumulation on progression to myelodysplasia/acute myeloid leukaemia (MDS/AML). Overall survival was 83{\%} at 10 years. CyA-dependence without a predictive marker was observed in 18{\%} of responders. Probability of discontinuing CyA was 60.5{\%} at 10 years; a slow CyA tapering schedule was performed in 84{\%} of patients; the cumulative incidence of relapse was 16{\%} at 10 years. Relapse risk was significantly associated with rapid CyA discontinuation: 60{\%} compared to 7.6{\%} in the slow tapering group (P = 0.001). Cumulative incidence of MDS/AML was 8{\%} at 10 years, with a significant correlation with both G-CSF cumulative dose and second IST. This long-term follow-up of children with AAA shows that IST with a slow CyA tapering course is an effective treatment with a low-relapse rate in these cases.",
keywords = "Aplastic anaemia, Children, Therapy",
author = "Paola Saracco and Paola Quarello and Iori, {Anna Paola} and Marco Zecca and Daniela Longoni and Johanna Svahn and Stefania Varotto and {Del Vecchio}, {Gian Carlo} and Carlo Dufour and Ugo Ramenghi and Andrea Bacigalupo and Anna Locasciulli",
year = "2008",
month = "1",
doi = "10.1111/j.1365-2141.2007.06903.x",
language = "English",
volume = "140",
pages = "197--205",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "John Wiley & Sons, Ltd (10.1111)",
number = "2",

}

TY - JOUR

T1 - Cyclosporin A response and dependence in children with acquired aplastic anaemia

T2 - A multicentre retrospective study with long-term observation follow-up

AU - Saracco, Paola

AU - Quarello, Paola

AU - Iori, Anna Paola

AU - Zecca, Marco

AU - Longoni, Daniela

AU - Svahn, Johanna

AU - Varotto, Stefania

AU - Del Vecchio, Gian Carlo

AU - Dufour, Carlo

AU - Ramenghi, Ugo

AU - Bacigalupo, Andrea

AU - Locasciulli, Anna

PY - 2008/1

Y1 - 2008/1

N2 - Immunosuppressive therapy (IST) with antithymocyte globulin and cyclosporin A (CyA) is the standard treatment for children with acquired aplastic anaemia (AAA) lacking a matched donor. Survival rates of more than 80% at 5 years are achieved, but the response is drug-dependent in 15-25% of cases. This study, of 42 consecutive children with AAA treated with IST, assessed the incidence of CyA-dependence, CyA and granulocyte colony-stimulating factor (G-CSF) tapering schedules and the impact of drug accumulation on progression to myelodysplasia/acute myeloid leukaemia (MDS/AML). Overall survival was 83% at 10 years. CyA-dependence without a predictive marker was observed in 18% of responders. Probability of discontinuing CyA was 60.5% at 10 years; a slow CyA tapering schedule was performed in 84% of patients; the cumulative incidence of relapse was 16% at 10 years. Relapse risk was significantly associated with rapid CyA discontinuation: 60% compared to 7.6% in the slow tapering group (P = 0.001). Cumulative incidence of MDS/AML was 8% at 10 years, with a significant correlation with both G-CSF cumulative dose and second IST. This long-term follow-up of children with AAA shows that IST with a slow CyA tapering course is an effective treatment with a low-relapse rate in these cases.

AB - Immunosuppressive therapy (IST) with antithymocyte globulin and cyclosporin A (CyA) is the standard treatment for children with acquired aplastic anaemia (AAA) lacking a matched donor. Survival rates of more than 80% at 5 years are achieved, but the response is drug-dependent in 15-25% of cases. This study, of 42 consecutive children with AAA treated with IST, assessed the incidence of CyA-dependence, CyA and granulocyte colony-stimulating factor (G-CSF) tapering schedules and the impact of drug accumulation on progression to myelodysplasia/acute myeloid leukaemia (MDS/AML). Overall survival was 83% at 10 years. CyA-dependence without a predictive marker was observed in 18% of responders. Probability of discontinuing CyA was 60.5% at 10 years; a slow CyA tapering schedule was performed in 84% of patients; the cumulative incidence of relapse was 16% at 10 years. Relapse risk was significantly associated with rapid CyA discontinuation: 60% compared to 7.6% in the slow tapering group (P = 0.001). Cumulative incidence of MDS/AML was 8% at 10 years, with a significant correlation with both G-CSF cumulative dose and second IST. This long-term follow-up of children with AAA shows that IST with a slow CyA tapering course is an effective treatment with a low-relapse rate in these cases.

KW - Aplastic anaemia

KW - Children

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=37249068118&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37249068118&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2141.2007.06903.x

DO - 10.1111/j.1365-2141.2007.06903.x

M3 - Article

VL - 140

SP - 197

EP - 205

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 2

ER -